Guest Editorial A “new normal” for NCI-sponsored clinical trials is long overdue November 18, 2022Vol.48 No.42By Richard L. Schilsky
A brief report sets forth a “new normal,” lets NCI start to streamline clinical trials November 11, 2022Vol.48 No.41By Paul Goldberg
Conversation with The Cancer Letter NCI’s Doroshow: “These recommendations are something that we can implement right away” November 11, 2022Vol.48 No.41By Paul Goldberg
NCI Bertagnolli sets out eight “core principles” for NCI: “We’ve got to be nimbler, faster” November 11, 2022Vol.48 No.41
In Brief Gregory Reaman named scientific director of NCI’s Childhood Cancer Data Initiative November 11, 2022Vol.48 No.41
Conversation with The Cancer Letter Children’s National and UCL team receives $25M Grand Challenges award to study CAR T in pediatric solid tumors November 04, 2022Vol.48 No.40By Jacquelyn Cobb
In Brief Cancer Grand Challenges launches global consultation to find cancer’s toughest challenges November 04, 2022Vol.48 No.40
NCI “Your work makes the rest of it work,” NCI Director Bertagnolli says to clinical trialists at ECOG-ACRIN meeting October 28, 2022Vol.48 No.39By Paul Goldberg
2022 Annual Report to the Nation: Overall cancer deaths continue to drop; some survival improvement in pancreatic cancer October 28, 2022Vol.48 No.39By Jacquelyn Cobb
In Brief Fox Chase and Weill Cornell Medicine selected as founding members of NCI prevention initiative October 28, 2022Vol.48 No.39
